Avadel Fin Cay Ltd/Avadel Pharma Plc's ticker is and the CUSIP is 05337YAA6. A total of 1 filers reported holding Avadel Fin Cay Ltd/Avadel Pharma Plc in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,668,000 | -49.5% | 5,300,000 | -51.8% | 0.68% | -50.0% |
| Q2 2021 | $11,213,000 | -8.7% | 11,000,000 | 0.0% | 1.35% | -49.2% |
| Q1 2021 | $12,279,000 | -16.0% | 11,000,000 | -24.1% | 2.66% | +43.6% |
| Q4 2020 | $14,618,000 | +17.5% | 14,500,000 | +7.4% | 1.86% | -28.8% |
| Q3 2020 | $12,437,000 | +3.1% | 13,500,000 | +12.5% | 2.60% | -12.7% |
| Q2 2020 | $12,060,000 | – | 12,000,000 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 14,500,000 | $14,618,000 | 1.86% |